Further investigation should analyze the expression of SPEF1 and SPEF2 in a larger cohort of BLCA cases, thereby correlating these results with clinicopathological data, patient follow-up, and therapeutic strategies. Here, SPEF1 is linked to bladder transitional cell carcinoma.